Cargando…
Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs
BACKGROUND: Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its influence on readmissions and costs. METHODS: A single-ce...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827191/ https://www.ncbi.nlm.nih.gov/pubmed/35139838 http://dx.doi.org/10.1186/s12913-022-07582-6 |
_version_ | 1784647577071779840 |
---|---|
author | Lázaro Cebas, Andrea Caro Teller, José Manuel García Muñoz, Carmen González Gómez, Carlos Ferrari Piquero, José Miguel Lumbreras Bermejo, Carlos Romero Garrido, José Antonio Benedí González, Juana |
author_facet | Lázaro Cebas, Andrea Caro Teller, José Manuel García Muñoz, Carmen González Gómez, Carlos Ferrari Piquero, José Miguel Lumbreras Bermejo, Carlos Romero Garrido, José Antonio Benedí González, Juana |
author_sort | Lázaro Cebas, Andrea |
collection | PubMed |
description | BACKGROUND: Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its influence on readmissions and costs. METHODS: A single-centre study with an intervention group and a retrospective control group was conducted. The intervention was carried out in all polymedicated patients ≥ 65 years who were admitted to internal medicine and signed the informed consent between June 2017 and February 2018. Patients discharged to nursing homes or long-term hospitals were excluded. The control group were all the patients who were admitted during the same months of 2014 who met the same inclusion criteria. The patients were classified according to the HOSPITAL score as having a low, intermediate, or high risk of potentially avoidable readmission. Outcome measures were 30-day readmission and cost data. To analyse the effect of the intervention on readmission, a logistic regression was performed. RESULTS: The study included 589 patients (286 intervention group; 303 control group). The readmission rate decreased from 20.13% to 16.43% in the intervention group [OR = 0.760 95% CI (0.495–1.166); p = 0.209)]. The incremental cost for the intervention to prevent one readmission was €3,091.19, and the net cost saving was €1,301.26. In the intermediate- and high-risk groups, readmissions were reduced 10.91% and 10.00%, and the net cost savings were €3,3143.15 and €3,248.71, respectively. CONCLUSIONS: The pharmacist intervention achieved savings in the number of readmissions, and the net cost savings were greater in patients with intermediate and high risks of potentially avoidable readmission according to the HOSPITAL score. |
format | Online Article Text |
id | pubmed-8827191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88271912022-02-10 Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs Lázaro Cebas, Andrea Caro Teller, José Manuel García Muñoz, Carmen González Gómez, Carlos Ferrari Piquero, José Miguel Lumbreras Bermejo, Carlos Romero Garrido, José Antonio Benedí González, Juana BMC Health Serv Res Research BACKGROUND: Patient education on pharmacological treatment could reduce readmissions. Our objective was to carry out a pharmacist intervention focused on providing information about high-risk medications to chronic patients and to analyse its influence on readmissions and costs. METHODS: A single-centre study with an intervention group and a retrospective control group was conducted. The intervention was carried out in all polymedicated patients ≥ 65 years who were admitted to internal medicine and signed the informed consent between June 2017 and February 2018. Patients discharged to nursing homes or long-term hospitals were excluded. The control group were all the patients who were admitted during the same months of 2014 who met the same inclusion criteria. The patients were classified according to the HOSPITAL score as having a low, intermediate, or high risk of potentially avoidable readmission. Outcome measures were 30-day readmission and cost data. To analyse the effect of the intervention on readmission, a logistic regression was performed. RESULTS: The study included 589 patients (286 intervention group; 303 control group). The readmission rate decreased from 20.13% to 16.43% in the intervention group [OR = 0.760 95% CI (0.495–1.166); p = 0.209)]. The incremental cost for the intervention to prevent one readmission was €3,091.19, and the net cost saving was €1,301.26. In the intermediate- and high-risk groups, readmissions were reduced 10.91% and 10.00%, and the net cost savings were €3,3143.15 and €3,248.71, respectively. CONCLUSIONS: The pharmacist intervention achieved savings in the number of readmissions, and the net cost savings were greater in patients with intermediate and high risks of potentially avoidable readmission according to the HOSPITAL score. BioMed Central 2022-02-09 /pmc/articles/PMC8827191/ /pubmed/35139838 http://dx.doi.org/10.1186/s12913-022-07582-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lázaro Cebas, Andrea Caro Teller, José Manuel García Muñoz, Carmen González Gómez, Carlos Ferrari Piquero, José Miguel Lumbreras Bermejo, Carlos Romero Garrido, José Antonio Benedí González, Juana Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs |
title | Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs |
title_full | Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs |
title_fullStr | Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs |
title_full_unstemmed | Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs |
title_short | Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs |
title_sort | intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827191/ https://www.ncbi.nlm.nih.gov/pubmed/35139838 http://dx.doi.org/10.1186/s12913-022-07582-6 |
work_keys_str_mv | AT lazarocebasandrea interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts AT carotellerjosemanuel interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts AT garciamunozcarmen interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts AT gonzalezgomezcarlos interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts AT ferraripiquerojosemiguel interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts AT lumbrerasbermejocarlos interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts AT romerogarridojoseantonio interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts AT benedigonzalezjuana interventionbyaclinicalpharmacistcarriedoutatdischargeofelderlypatientsadmittedtotheinternalmedicinedepartmentinfluenceonreadmissionsandcosts |